Characterization of a Northern German Primary Biliary Cholangitis Cohort

Area of Science:

• Hepatology
• Gastroenterology
• Internal Medicine

Background:

• Real-world data on risk stratification for primary biliary cholangitis (PBC) is scarce.
• Identifying high-risk PBC patients is essential for optimizing treatment strategies and preventing disease progression.
• Current management may not adequately address the needs of all PBC patient subgroups.

Purpose of the Study:

• To characterize a cohort of primary biliary cholangitis (PBC) patients.
• To identify risk factors associated with disease progression in PBC.
• To gain insights into PBC patient characteristics for improved clinical care.

Main Methods:

• Retrospective analysis of 535 PBC patients from a German university hospital.
• Evaluation of risk factors including response to ursodeoxycholic acid (UDCA), age, fibrosis (VCTE), and comorbidities.
• Assessment of treatment response based on established criteria (Paris II).

Main Results:

• PBC predominantly affects women aged 50-69; 27% had obesity (BMI ≥ 30 kg/m²).
• Younger patients (<50 years) and those with advanced fibrosis (VCTE ≥ 10 kPa) showed lower UDCA treatment response rates.
• Autoimmune hepatitis variant syndrome did not significantly impact UDCA treatment response compared to PBC alone.

Conclusions:

• Risk stratification in PBC is vital for tailoring treatment intensity.
• Advanced fibrosis and younger age are indicators of potentially poorer outcomes in PBC patients.
• Understanding comorbidities and risk factors can optimize PBC management and patient care.